[prev in list] [next in list] [prev in thread] [next in thread]
List: evolution
Subject: [Evolution] HOT NEW BIOTECH COMPANY IN BARRONS THIS WEEK!!
From: HotStock () real ! com
Date: 2000-09-29 0:25:57
Message-ID: 200009290428.MAC23030 () baosoft ! com
[Download RAW message or body]
Text version below:
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<meta name="GENERATOR" content="Microsoft FrontPage 4.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<title>Dnaprint</title>
</head>
<body>
<p><b><font color="#000000" face="Arial" size="4"> </font><font color="#000000" \
size="2"><font color="#000000" size="4">Dnaprint</font><font color="#0000ff" \
size="4"> (</font><font color="#cc0000" size="4">DNAP</font><font color="#0000ff" \
size="4">) </font><font color="#000000" size="4">is an</font><font color="#0000ff" \
size="4"> </font><font color="#000000" size="4">emerging biotech company in this \
weeks </font><font color="#cc0000" size="4">Barrons</font><font color="#000000" \
size="4">.</font></font></b></p> <p><br>
<font color="#000080" size="4">1) CEO (Dr. Tony Frudakis) Lead scientist for
Corixa starts his own company a few months ago<br>
<br>
2) Company is formed by a reverse merger of a pinksheet company<br>
<br>
3) DNAP has already completed the accounting to get off the pinksheets and
should be listed on the OTCBB soon.<br>
<br>
4) Dr. Frudakis was responsible for a patent that sold for $54,000,000 to Smith
Kline Beecham while he was at Corixa.<br>
<br>
5) Corixa's stock has gone from 14 Cents a few years ago to 50 Dollars today.<br>
<br>
6) According to the Barron's article, Dnaprint is in the late stages of forming
strategic alliances with major companies.</font></p>
<p><font color="#000080" size="4">7) </font><font size="4" \
color="#CC0000">DNAP</font><font color="#000080" size="4"> is trading at 23.5 cents \
as of Friday's close !!!!!!!!!!!!!!!</font></p> <p><font size="2"> This is not \
from a registered financial advisory, please consult with a registered investment \
advisor before making an investment decision. This communication (print or \
electronic) reflects our opinions and does not necessarily reflect those of anyone \
else related to the firm and may be in conflict with the views or official views of \
the companies mentioned. Readers are advised that this publication (print or \
electronic) is issued solely for informational purposes and is not to be construed as \
an offer to sell or the solicitation of an offer to buy. This communication is based \
on information available to the public. We are NOT a professional advisory service, \
broker, investment firm or agency. We are NOT a stock picking service. The securities
profiled here are solely of our own opinion and it is not recommended that you
buy, sell, or hold based on what you find here. Please continue to perform your
own Due Diligence. Any investment decisions you make should be your own
predicated upon your own findings and judgments born from your own research. All
images and logo's used to represent DNAPrint are registered trademarks of
DNAPrint. Barrons is a registered trademark of Dow Jones & Co., Inc..</font><font \
size="1"><br> </font><font color="#000080" size="4"><br>
</font></p>
</body>
</html>
TEXT Version:
Dnaprint (DNAP) is an emerging biotech company in this weeks Barrons.
1) CEO (Dr. Tony Frudakis) Lead scientist for Corixa starts his own company a
few months ago
2) Company is formed by a reverse merger of a pinksheet company
3) DNAP has already completed the accounting to get off the pinksheets and
should be listed on the OTCBB soon.
4) Dr. Frudakis was responsible for a patent that sold for $54,000,000 to
Smith Kline Beecham while he was at Corixa.
5) Corixa's stock has gone from 14 Cents a few years ago to 50 Dollars today.
6) According to the Barron's article, Dnaprint is in the late stages of forming
strategic alliances with major companies.
7) Dnap is trading at 23.5 cents at Friday's close !!!!
[prev in list] [next in list] [prev in thread] [next in thread]
Configure |
About |
News |
Add a list |
Sponsored by KoreLogic